AI assistant
Biohit Oyj — Board/Management Information 2022
Aug 22, 2022
3304_iss_2022-08-22_b76163f5-694a-4638-83b2-8610d67c92a1.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Changes to Biohit Oyj's management
Publishing on August 22, 2022 at 13:30 am local time (EEST)
Head of Technical Product Management Panu Hendolin, PhD, has been appointed member of the Management Team of Biohit Oyj starting September 1, 2022. Hendolin is responsible for innovation and life cycle management of the medical devices. Hendolin reports to CEO Päivi Siltala.
Hendolin has worked at Biohit as R&D and Production Director in 2007-2008, as well as 2012- 2017, and he returned to the company in February 2022. In the meanwhile, Hendolin worked as Production Director at United Medix Laboratories Oy and Chief Technology Officer at Sulapac Oy. Hendolin has the degree of Ph.D. in molecular medicine.
Additional information:
Päivi Siltala, CEO, Biohit Oyj, tel. +358 50 460 9510
[email protected] www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is "Innovating for Health" – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com